Ori Biotech raises over $100 million in Series B funding
Innovative cell and gene therapy manufacturing platform
25-Jan-2022 -
Ori Biotech Ltd. (Ori), a start-up in cell and gene therapy (CGT) manufacturing technology, announced it has secured over $100 million in an oversubscribed Series B funding round. The investment round was led by Novalis LifeSciences with Puhua Capital and Chimera Abu Dhabi coming in as new ...
cell therapies
gene therapy
Series B financing